Avricore Health (AVCRF) Non Operating Investment Income (2023 - 2024)

Avricore Health (AVCRF) reported Non Operating Investment Income of -$131264.2 for Q3 2024, up 38.27% year-over-year from -$94934.5 in Q4 2023, and up 38.27% quarter-over-quarter from -$212636.4 in Q3 2023.

Avricore Health (AVCRF) Non Operating Investment Income (2023 - 2024) Analysis & Trends

Avricore Health (AVCRF) has 2 years of Non Operating Investment Income data on file, last reported at -$131264.2 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Waters 30,010.71 Bn 30,010.25 Bn 1.11 Bn -
2 Thermo Fisher Scientific 179.46 Bn 176.21 Bn 7.74 Bn -
3 Danaher 130.33 Bn 124.64 Bn 3.59 Bn -
4 Idexx Laboratories 44.44 Bn 44.24 Bn 722.74 Mn -
5 Agilent Technologies 37.27 Bn 35.46 Bn 990.00 Mn -
6 Iqvia Holdings 30.70 Bn 28.73 Bn 1.36 Bn -
7 Natera 30.59 Bn 29.49 Bn 696.04 Mn -
8 Illumina 24.86 Bn 23.71 Bn 721.00 Mn -
9 Mettler Toledo International 23.06 Bn 23.00 Bn 555.82 Mn -
10 Avricore Health - - - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -131,264.21
Sep 30, 2024 -131,264.21
Sep 30, 2023 -212,636.43
Sep 30, 2023 -212,636.43